44 min listen
Donanemab: A New Ray of Hope in the Fight Against Alzheimer's
Donanemab: A New Ray of Hope in the Fight Against Alzheimer's
ratings:
Length:
48 minutes
Released:
May 11, 2023
Format:
Podcast episode
Description
Welcome to the latest episode of our podcast, where we discuss the latest breakthrough in the fight against Alzheimer's disease. In today's episode, we discussed the new monoclonal antibidy, Donanemab, that is offering hope to Alzheimer's patients and their families, and how Donanemab is different from other treatments. Donanemab is a monoclonal antibody that has shown promising results in clinical trials. It works by targeting a protein called amyloid-beta, which is believed to play a significant role in the development of Alzheimer's disease. The drug binds to the amyloid-beta protein and clears it from the brain, reducing the amount of plaque buildup that causes damage to brain cells. While the results of the clinical trials are promising, there are still many challenges to overcome. Donanemab is expensive and requires regular infusions, which may limit its accessibility. There is also a need for further research to determine the long-term effects of the drug and its efficacy in treating different stages of Alzheimer's. Follow us: Join the NEURO Academy: NEUROacademy.com Follow us on social media: Instagram: The Brain Docs @thebraindocs Facebook: The Brain Docs TikTok: @thebraindocs Website: TheBrainDocs.com
Released:
May 11, 2023
Format:
Podcast episode
Titles in the series (78)
A Transformative Leader Revolutionizing Healthcare - Brooklyn Borough President Eric Adams: In this episode, we sat down with Brooklyn Borough President, Eric Adams, a dynamic leader and a luminary who is changing healthcare as we know it. He previously served three terms in the New York State Senate and 22 years in the New York City Police... by The Brain Health Revolution Podcast